Title : Relative remission rates of Janus kinase inhibitors in comparison with adalimumab in patients with active rheumatoid arthritis: a network meta-analysis.

Pub. Date : 2022 Feb 10

PMID : 35142908






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 The filgotinib 200 mg + MTX and upadacitinib 15 mg + MTX groups showed a significantly higher DAS28-CRP < 2.6 than adalimumab 40 mg + MTX. Methotrexate C-reactive protein Homo sapiens
2 The filgotinib 200 mg + MTX and upadacitinib 15 mg + MTX groups showed a significantly higher DAS28-CRP < 2.6 than adalimumab 40 mg + MTX. Methotrexate C-reactive protein Homo sapiens